Shortened LSD therapy for major depression
Treatments studied
Part of Mental health clinical trials.
This study tests whether a shorter LSD session can help people with major depression. It aims to see if the treatment is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with major depression and have a severe episode (score of 28 or higher on a depression scale).
- You can read, write, and speak English fluently.
- You are at low risk for hurting yourself, as judged by the study doctors.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you use effective birth control.
- Your heart is healthy, with normal blood pressure and no serious heart conditions.
- You do not have epilepsy, insulin-dependent diabetes, or a history of seizures.
- You are not taking certain medications like antipsychotics, MAO inhibitors, or specific antidepressants that cannot be stopped.
- You do not have a history of psychosis, bipolar disorder, or a family member with these conditions.
- You are not severely overweight (BMI under 40, or under 35 without high blood pressure or diabetes).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a single dose of psilocybin, given while you are under anesthesia, can help treat major depression. You will be monitored closely during and after the session.
This Phase 2 trial studies whether an LSD treatment approach, combined with study procedures, can help people with moderate-to-severe alcohol use disorder cut down or stop drinking. It may help reset patterns around cravings and drinking, but it also requires careful safety screening.
This study tests if psilocybin (a psychedelic) combined with cognitive behavioral therapy (CBT) can help people with major depression. You would receive the psilocybin in a supervised setting and have talk therapy before and after.
This trial tests whether a single dose of psilocybin can help people with treatment-resistant depression by changing how they focus on themselves. It aims to understand how psilocybin affects brain activity and self-related thinking.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.
This trial tests whether psilocybin can help people with major depression who are currently having a depressive episode. It aims to understand how the treatment works and if it is safe and effective.
Hear when a new Major Depression Moderate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.